Ottawa Public Health is recommending that eligible residents at higher risk of severe illness protect themselves against respiratory syncytial virus (RSV) this respiratory illness season, including infants and high-risk children.
According to OPH, RSV is a respiratory virus that “can be particularly severe in infants and older adults.” OPH says Immunization against RSV can help prevent serious health outcomes, including hospitalization. Publicly funded immunization is available for infants, high-risk children, pregnant individuals, and eligible older adults.
- Sign up now for daily CTV News Ottawa newsletters
- The information you need to know, sent directly to you: Download the CTV News App
RSV protection for infants and high-risk children
Ottawa Public Health recommends that infants and high-risk children receive protection against RSV this respiratory virus season. The National Advisory Committee of Immunization recommends Beyfortus, a monoclonal antibody (preventative antibody), for infants.
Beyfortus is recommended for infants due to its effectiveness, long-lasting protection (up to 6 months), and safety, according to Ottawa Public Health.
The Ontario Ministry of Health’s …